University of Groningen Co-prescription of antiepileptic drugs and contraceptives

Background: Enzyme-inducing antiepileptic drugs (AEDs) reduce the efficacy of oral contraceptives. Little is known of contraceptive practice among reproductive-age women who receive AEDs. Study Design: We explored the use of contraceptive methods among Dutch women aged 15 to 49 years with prescriptions of AEDs using pharmacy dispensing database. Drug dispensing data of AEDs and contraceptives in 2006 was retrieved from the InterAction Database (IADB.nl database). The prevalence of contraceptives use and distribution of different contraceptive methods were calculated. Results: Of women who used enzyme-inducing AEDs in combination with any highly effective contraceptive method, over 40% were on an oral contraceptive (OC) containing b50 mcg estrogen. IUDs and injectable contraception were used in 22.5% of women receiving AEDs in combination with any highly effective contraceptive method, and 33.2% in those receiving enzyme-inducing AEDs in combination with any highly effective contraceptive method. Conclusion: Fertile-age women who received AEDs often relied on less effective contraceptive methods. Prescribers should be more aware of the interaction between AEDs and OCs. © 2012 Elsevier Inc. All rights reserved.

[1]  M. Loane,et al.  Valproic acid monotherapy in pregnancy and major congenital malformations. , 2010, The New England journal of medicine.

[2]  A. Pack,et al.  Antiepileptic drugs: Are women aware of interactions with oral contraceptives and potential teratogenicity? , 2009, Epilepsy & Behavior.

[3]  A. Pack,et al.  Reproductive history, sexual behavior and use of contraception in women with epilepsy. , 2008, Contraception.

[4]  J. Simon,et al.  The impact of antiepileptic drug therapy on steroidal contraceptive efficacy , 2006, Epilepsy & Behavior.

[5]  J. Sidhu,et al.  The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. , 2006, British journal of clinical pharmacology.

[6]  G. Montouris,et al.  Knowledge of women’s issues and epilepsy (KOWIE-II): a survey of health care professionals , 2005, Epilepsy & Behavior.

[7]  H. Tobi,et al.  How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information , 2004, Pharmacoepidemiology and drug safety.

[8]  S. Shorvon,et al.  Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice , 2002, Journal of neurology, neurosurgery, and psychiatry.

[9]  M. Morrell,et al.  Health issues for women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare providers. , 2000, Journal of women's health & gender-based medicine.

[10]  Lolkje T. W. de Jong-van den Berg,et al.  The InterAction Database: Synergy of Science and Practive in Pharmacy , 2000, ISMDA.

[11]  P. Crawford,et al.  Gender difference in management of epilepsy—what women are hearing , 1999, Seizure.

[12]  Practice Parameter: Management Issues for Women with Epilepsy (Summary Statement) , 1998, Epilepsia.

[13]  J. Brandt,et al.  Antiepileptic medication and oral contraceptive interactions , 1996, Neurology.